Brian drives Galyatech forward with his passion and vision.
Caris takes care of administration and pays the bills at Galyatech.
Andrew runs the daily operations of moving things forward at Galyatech.
Scientific Advisory Board
Dr. Cristin Davidson, PhD
Cristin has researched NPC for over a decade and now works closely with investigators studying gene therapy in Npc1 mice.
Dr. Steven Gray, PhD
Steven directed the development and testing of gene therapy for GAN (a rare neurological disorder), which began a Phase 1 trial in 2015.
UPenn is home to the only large animal model of NPC, the NPC1 cat colony. Appropriately, this feline colony is under the guidance and care of a prominent NPC researcher, Dr. Charles Vite. Moreover, UPenn is a leader in gene therapy and is also home to gene therapy pioneer, Dr. Jim Wilson.
Galyatech has raised millions of dollars from private sources – having received no venture capital – meaning we have full control of our decisions.